Back to JPMorgan Chase & Co. JPMorgan Chase & Co.

ADGM

5 quarters

Position history for JPMorgan Chase & Co.JPMorgan Chase & Co.'s holdings in Adagio Medical Holdings, Inc

No. JPMorgan Chase exited its ADGM (Adagio Medical Holdings) position in Q2 2026. Its Q1 2026 13F listed 975 shares worth $1,053. JPMorgan Chase first reported ADGM in Q4 2024 and held it in 3 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$105,000

Total Shares Change

-100,000

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$0.65
0
2026-Q1
New
975
-
$1,0530.0%$1.15
17
2025-Q2
Exited
0
-100.0%
$00.0%$1.30
0
2025-Q1
Unchanged
100,000
0.0%
$79,5100.0%$0.81
0
2024-Q4
New
100,000
-
$105,0000.0%$1.05
33

Other major holders of ADGM: RA Capital Management, L.P., Adage Capital Partners GP, L.L.C., Alyeska Investment Group, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used